Plausibility and Undue Burden: A New Look at Insufficiency after FibroGen v Akebia
FibroGen Inc. v Akebia Therapeutics Inc. and another company; Astellas Pharma Inc. v Akebia Therapeutics
December 2, 2021
Popular Articles
Read articles from our member community with the most views.
Recent Articles
Some recent articles from our member community.
Patent Filing Litigations Continue to Increase Despite the COVID-19 Pandemic
Looking back at the past decade, in 2013, filings of
azami
February 2, 2022
Getting the Most from Medical-Use Claims in Australia
Australia stands apart from many other key jurisdictions in allowing
azami
December 2, 2021
Plausibility and Undue Burden: A New Look at Insufficiency after FibroGen v Akebia
FibroGen Inc. v Akebia Therapeutics Inc. and another company; Astellas
azami
December 2, 2021
Get our insights delivered straight to your inbox.
